NMDAE Clinical Trials
7 recruitingDrug
Phase 27
Showing 1–7 of 7 trials
Recruiting
Phase 2
Monotherapy of an NMDA Enhancer for Schizophrenia
Schizophrenia
China Medical University Hospital80 enrolled1 locationNCT04745143
Recruiting
Phase 2
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
Prodromal Schizophrenia
China Medical University Hospital48 enrolled1 locationNCT05052853
Recruiting
Phase 2
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
Schizophrenia
China Medical University Hospital90 enrolled1 locationNCT07122895
Recruiting
Phase 2
NMDA Modulation in Major Depressive Disorder
Major Depressive Disorder
China Medical University Hospital90 enrolled1 locationNCT04637620
Recruiting
Phase 2
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
Bipolar I Disorder
China Medical University Hospital90 enrolled1 locationNCT05977023
Recruiting
Phase 2
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
Schizophrenia
China Medical University Hospital90 enrolled1 locationNCT06021197
Recruiting
Phase 2
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
Major Depressive Disorder
China Medical University Hospital50 enrolled1 locationNCT05136755